SMC
ALAB icon

Smith, Moore & Co’s Astera Labs ALAB Stock Holding History

Smith, Moore & Co’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
+525
New +$139K 0.02% 501

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Smith, Moore & Co's ALAB Position: Q2 2026 in Review

Smith, Moore & Co opened a new position in Astera Labs (ALAB) in Q2 2026: 525 shares worth $254K. The stake represents 0.02% of the portfolio and ranks #501 among its holdings.

981 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Smith, Moore & Co held 525 shares of Astera Labs worth $254K as of Q2 2026.
  • Astera Labs was a new Smith, Moore & Co position in Q2 2026.
  • Astera Labs made up 0.02% of Smith, Moore & Co's portfolio in Q2 2026, its #501 holding.
  • 981 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.